Karo Pharma AB (Karo Pharma AB) Other Long Term Assets : $67.2 Mil (As of Jun. 2022)

View and export this data going back to . Start your Free Trial

What is Karo Pharma AB Other Long Term Assets?

Karo Pharma AB's other long-term assets for the quarter that ended in Jun. 2022 was $67.2 Mil.

Karo Pharma AB's quarterly other long-term assets declined from Sep. 2021 ($78.7 Mil) to Dec. 2021 ($73.1 Mil) but then stayed the same from Dec. 2021 ($73.1 Mil) to Jun. 2022 ($67.2 Mil).

Karo Pharma AB's annual other long-term assets increased from Dec. 2019 ($64.0 Mil) to Dec. 2020 ($82.2 Mil) but then declined from Dec. 2020 ($82.2 Mil) to Dec. 2021 ($73.1 Mil).

Karo Pharma AB Other Long Term Assets Historical Data

The historical data trend for Karo Pharma AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karo Pharma AB Other Long Term Assets Chart

Karo Pharma AB Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Other Long Term Assets

Get a 7-Day Free Trial

9.50

58.81

63.96

82.21

73.14

Karo Pharma AB Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Jun22
Other Long Term Assets	Get a 7-Day Free Trial															79.12	80.51	78.67	73.14	67.23

Karo Pharma AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Karo Pharma AB (Karo Pharma AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Karo Pharma AB (OTCPK:KARBF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Klara Norra Kyrkogata 33, Stockholm, SWE, 111 22

Website

https://www.karopharma.com

Karo Pharma AB is a healthcare corporation. It is engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of development and sale of products to pharmacies, digital distribution channels and food stores. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.

Karo Pharma AB (Karo Pharma AB) Headlines

From GuruFocus

Avista Capital Partners To Sell Trimb To Karo Pharma

By PRNewswire PRNewswire • 06-25-2019